Evidence from a real world cohort of patients with hepatitis C treated with direct acting antivirals has countered the findings of a Cochrane Review that claimed the drugs did not reduce morbidity or mortality. Findings from a multicentre French study that followed up more than 10,000 adult patients with chronic HCV for three years showed that ...
DAA study counters Cochrane doubts about HCV mortality & morbidity
By Michael Woodhead
15 Feb 2019